Background To determine clinical-pathologic variables in patients with a new diagnosis of hepatocellular carcinoma (HCC) and underlying hepatitis B vs. C infection. Methods Patients presenting to ...

Younger age, substance use, and HCC may be risk factors for repeat HCV viremia in patients who achieve SVR following DAA therapy.

The incidence of hepatocellular carcinoma (HCC) has increased in Australia in recent decades, a large and growing proportion of which occurs among a population chronically infected with hepatitis ...

Further studies that carefully assess risk factors for HCC occurrence after HCV viral eradication are needed to optimize individualized surveillance approaches. Hepatitis C virus (HCV) infection ...

In other parts of the world, chronic hepatitis C and hepatitis B are the major contributors to HCC burden. In the U.S., however, alcohol-associated liver disease and metabolic syndrome are also ...

Liver cancer is the sixth leading cause of cancer death in the U.S. The most common type of liver cancer in adults is ...

Statins appeared to reduce the risk for hepatocellular carcinoma and hepatic decompensation among patients with chronic liver ...

Hepatitis B virus (HBV) infection is associated with liver diseases, including chronic hepatitis, which notably increases the risk of cirrhosis and hepatocellular carcinoma (HCC) development. Although ...

It is the most common form of primary liver cancer and typically occurs in individuals with a chronic liver disease, such as cirrhosis and hepatitis B or C infections. "HCC ranks as the third ...